Albion Financial Group’s Axonics, Inc. Common Stock AXNX Stock Holding History

Albion Financial Group’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-45	Closed	-$3.13K	–	701
2024 Q3	$3.13K	Hold	45	–	–	﹤0.01%	398
2024 Q2	$3.03K	Hold	45	–	–	﹤0.01%	405
2024 Q1	$3.1K	Hold	45	–	–	﹤0.01%	388
2023 Q4	$2.8K	Hold	45	–	–	﹤0.01%	383
2023 Q3	$2.53K	Hold	45	–	–	﹤0.01%	366
2023 Q2	$2.27K	Hold	45	–	–	﹤0.01%	378
2023 Q1	$2.46K	Hold	45	–	–	﹤0.01%	364
2022 Q4	$2.81K	Hold	45	–	–	﹤0.01%	369
2022 Q3	$3K	Hold	45	–	–	﹤0.01%	381
2022 Q2	$3K	Hold	45	–	–	﹤0.01%	403
2022 Q1	$3K	Hold	45	–	–	﹤0.01%	454
2021 Q4	$3K	Hold	45	–	–	﹤0.01%	498
2021 Q3	$3K	Hold	45	–	–	﹤0.01%	446
2021 Q2	$3K	Buy	+45	New	+$2.66K	﹤0.01%	438
2020 Q4	$2K	Buy	+45	New	+$2.11K	﹤0.01%	436

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Albion Financial Group's AXNX Position: Q4 2024 in Review

Albion Financial Group sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 45 shares — an estimated $3.13K sold.

Albion Financial Group first reported a position in AXNX in Q4 2020 and held it in 15 quarters. The position peaked at $3.13K in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Albion Financial Group reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Albion Financial Group sold 45 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $3.13K.
Albion Financial Group first reported a position in Axonics, Inc. Common Stock in Q4 2020 and held it in 15 quarters.
Albion Financial Group's Axonics, Inc. Common Stock position peaked at $3.13K in Q3 2024.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Albion Financial Group's 13F filing for Q4 2024, filed 17 Jan 2025.